In 2002, digital diagnostic technology was developed with the creation of AQUA (Automated Quantitative Analysis) at Yale Cancer Center to analyze microarray specimens in cancer research.

AQUA™ enabled researchers to localize and quantify proteins in tissue while maintaining spatial relationships — a process that was previously impossible with conventional methods of pathology analysis and which vastly increases the quality and amount of information for analysis.

HistoRx, a bioscience company offering novel digital technologies for in situ diagnostics developed at the School of Medicine has exclusive license to the AQUA™ (Automated Quantitative Analysis) technology developed by two of the company’s founders, Dr. David Rimm and Dr. Robert Camp, both in Yale’s Department of Pathology.